Deferred Tax Assets, Valuation Allowance of CLOVER HEALTH INVESTMENTS, CORP. /DE from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
CLOVER HEALTH INVESTMENTS, CORP. /DE Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $407,997,000, a 1.8% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

CLOVER HEALTH INVESTMENTS, CORP. /DE Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$407,997,000	+$7,188,000	+1.8%	31 Dec 2025	10-K	27 Feb 2026	2025	FY
Q4 2024	$400,809,000	+$3,903,000	+0.98%	31 Dec 2024	10-K	27 Feb 2026	2025	FY
Q4 2023	$396,906,000	+$27,376,000	+7.4%	31 Dec 2023	10-K	03 Mar 2025	2024	FY
Q4 2022	$369,530,000	+$93,665,000	+34%	31 Dec 2022	10-K	14 Mar 2024	2023	FY
Q4 2021	$275,865,000	+$112,661,000	+69%	31 Dec 2021	10-K	01 Mar 2023	2022	FY
Q4 2020	$163,204,000			31 Dec 2020	10-K	28 Feb 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.